DIGITAL HEALTH RESOURCE LIBRARY · STUDY PROTOCOL

Survivor Advocacy Dashboard

Illustrated pathway for this page

Supports survivor advocacy work by tracking advocacy priorities, stories and engagement without exposing clinical records.

Educational profile reviewed October 6, 2026 · Registry reference d8291eff-e005-4fb8-ba2a-8191605df13e

Access and learning pathway

Review current member eligibility, primary tool selection, and access terms in the verified member pathway. The complimentary program assigns one primary digital tool to each seat. Your approved internship study access follows its own reviewer pathway.

Review member access arrangements

Product mapping confirmed in the provider registry on October 23, 2026. Open licensed applications through your assigned member access pathway.

This study protocol helps you prepare an evaluation, record observations, and identify questions for the tool owner. Confirm the available features and current instructions in the tool before performing the fictional test.

Product evidence and next test

Advocacy application · partial workflow evidence

The live provider registry confirms the advocacy project. Current source has public resources and protected personal routes. The inspected scheduling and care-plan action buttons display toast messages; task completion for those controls remains unsupported.

Current task: Evaluate one fictional advocacy item and verify its tags, filtering, and persistence.

Access: Provider account for personal routes, applicable primary entitlement, and the stated story permissions.

Acceptance evidence needed: Identify the implemented priority and tagging workflow and verify save/read behavior. Confirm scheduling and care-plan actions reach working destinations before using those claims in a demonstration.

Production workflow verification remains pending following restricted browser access on October 23, 2026. Saved study notes belong to the CSPN notebook; product workflow and product storage each require their own acceptance test.

Who benefits

  • Advocates organising priorities across a season
  • Research interns studying how advocacy themes are categorised
  • Operations interns reviewing engagement follow-up

Original fictional study scenario

Use the current task and acceptance notes above when planning your evaluation.

Fictional example: "Advocate Jordan M." logs a fictional priority — clearer cardio-oncology follow-up reminders — tags it, and links it to an engagement event with no names or diagnoses recorded.

Study sequence

  1. Read the survivor-story permission rules first.
  2. Add or review advocacy priorities and tag their themes.
  3. Record engagement events at a summary level.
  4. Only include a story when written permission exists, and never clinical detail.

Outputs to examine

  • Tagged advocacy priorities
  • Engagement summaries
  • Theme counts over time

Focused evaluation

Enter a synthetic priority with an invented theme and confirm it can be tagged and filtered without any personal field.

Your tailored study record

Save and revisit this work

Save fictional examples and approved program learning material to your CSPN notebook. Each save creates a new revision available to you and authorized program reviewers. Use the private care channel agreed with your clinical team for personal health records.

Loading your notebook access…

Survivor Advocacy Dashboard

Registry reference: d8291eff-e005-4fb8-ba2a-8191605df13e

Fictional advocacy priority
Unanswered

How the priority reaches a responsible contact
Unanswered

Approved material and privacy boundaries
Unanswered

Follow-up owner, date, and success measure
Unanswered

Carry this into your internship

Link the saved notebook reference to your weekly journal, explain the role-specific learning, and submit any evidence through Secure Uploads. Record uncertain capabilities as questions for the tool owner.

Your privacy choices

Essential technologies keep the portal secure and functional. Optional analytics help COIM Inc. understand engagement and improve the experience.